Serum Institute of India, Pune became the second company after Pfizer to apply for an emergency use authorization for its trial vaccine, the Oxford COVID-19 vaccine (called COVISHIELD) in the country. The vaccine is currently undergoing phase III testing in India and other parts of the world. The news, which …
Read More »Coronavirus Vaccine Update: As Pfizer and Covishield seek approvals in India, how soon can we expect a vaccine?
